Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Mutagenicity and Carcinogenicity

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...

Serum Laboratory Studies, Stool Test, Breath Test

Serum Laboratory Studies, Stool Test, Breath Test

Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Adherence to the Mediterranean diet and risk of pancreatic cancer: an analysis of 2.3 million participants in the Pooling Project of Prospective Studies of Diet and Cancer (DCPP).

European journal of epidemiology·2026

Same author

Cell Phone Radiation Exposure Limits and Engineering Solutions.

International journal of environmental research and public health·2023

Same author

Associations of life course obesity with endometrial cancer in the Epidemiology of Endometrial Cancer Consortium (E2C2).

International journal of epidemiology·2023

Same author

The OncoSim-Breast Cancer Microsimulation Model.

Current oncology (Toronto, Ont.)·2022

Same author

The Critical Importance of Molecular Biomarkers and Imaging in the Study of Electrohypersensitivity. A Scientific Consensus International Report.

International journal of molecular sciences·2021

Same author

Estimating the future cancer management costs attributable to modifiable risk factors in Canada.

Canadian journal of public health = Revue canadienne de sante publique·2021

Search research articles

Related Experiment Video

Updated: Jun 18, 2026

Screening Ion Channels in Cancer Cells

Screening Ion Channels in Cancer Cells

Published on: June 16, 2023

Conundrums in screening for cancer.

Anthony B Miller¹

¹Dalla Lana School of Public Health, University of Toronto, ON, Canada. ab.miller@sympatico.ca

International Journal of Cancer

|December 5, 2009

Summary

Cancer screening programs require careful organization, considering disease natural history and potential harms versus benefits. Population-wide screening is currently justified only for breast and cervical cancers.

Area of Science:

Oncology
Public Health
Preventive Medicine

Background:

Cancer screening aims to detect malignancies early, but requires careful organization and understanding of disease progression.
Screening initiatives carry both significant potential benefits and risks that must be weighed.
The efficacy and justification of population-wide screening vary by cancer type.

Purpose of the Study:

To review the current state of screening technologies and policies for major cancers.
To evaluate the evidence supporting population-wide screening for breast, cervical, and prostate cancers.
To determine which cancer screening programs are currently justified.

Main Methods:

Literature review of the current state of the art in cancer screening.

More Related Videos

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

Published on: December 26, 2016

Related Experiment Videos

Last Updated: Jun 18, 2026

Screening Ion Channels in Cancer Cells

Screening Ion Channels in Cancer Cells

Published on: June 16, 2023

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

Published on: December 26, 2016

Analysis of the benefits and harms associated with screening protocols.

Assessment of existing population-based screening policies.

Main Results:

Breast cancer screening policies are justified in the population.
Cervical cancer screening policies are justified in the population.
Prostate cancer screening policies are not currently justified for population-wide implementation.

Conclusions:

Effective cancer screening necessitates a thorough understanding of the disease's natural history.
Population-wide screening is demonstrably beneficial and justified for breast and cervical cancers.
Further research or policy changes are needed regarding prostate cancer screening justification.